Immunocompromised patients with bladder cancer who undergo TURBT followed by BCG immunotherapy have worse survival outcomes compared to non-immunocompromised patients, a study suggests.

RPM improves postoperative functional recovery and symptoms among patients undergoing surgery for cancer, according to a study.

Overall, 41.7% of cancer deaths in 2023 were attributed to potentially modifiable risk factors, with behavioral risk factors having the greatest impact.

Millions who buy their health insurance on Affordable Care Act marketplaces will pay higher premiums next year.

In breast cancer patients with a high recurrence score, the 5-year disease-free rate was significantly higher for patients receiving taxanes with anthracycline and cyclophosphamide than for those ...

Men who improve their adherence to ACS guidelines following diagnosis have a reduction in all-cause and cardiovascular mortality compared to those who maintain a low concordance with guideline ...

A majority of children in the US rely on Medicaid or the Children’s Health Insurance Program at some point by their 18th birthday, and many experience periods of coverage loss, according to a study ...

The effectiveness of daily low-dose aspirin in reducing cancer risk varied widely across the study cohort, indicating personalized treatment approaches would be beneficial. Clonal hematopoiesis of ...

The AACR Cancer Progress Report 2025 highlights recent advances in cancer research, emphasizing the importance of federal funding.

This article was originally published on Stateline. A new Trump administration rule bars immigrants living in the United States under Deferred Action for Childhood Arrivals (DACA) from buying health ...

Subcutaneous isatuximab plus bortezomib, lenalidomide, and dexamethasone is effective in transplant-ineligible, newly diagnosed multiple myeloma.

A regulatory decision is expected during the first quarter of 2026. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for ...